abstract |
The present invention relates to an anti-aging composition comprising an angiotensin II type 1 receptor blocker as an active ingredient to prevent or inhibit aging. More specifically, the present invention, the use of carbon tetrachloride in the aging model animal SMP30 knockout mice chronically induced liver damage, hepatic fibrosis, and the expression of angiotensin II type 1 receptor blocker confirmed through the degree of expression and liver fibrosis of damaged liver It relates to anti-aging use. |